1
|
The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome.
|
Proc Natl Acad Sci U S A
|
2009
|
1.28
|
2
|
Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients.
|
Clin Nutr
|
2007
|
0.96
|
3
|
Effects of interleukin-15 on lipid oxidation: disposal of an oral [(14)C]-triolein load.
|
Biochim Biophys Acta
|
2006
|
0.95
|
4
|
Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine.
|
Biochim Biophys Acta
|
2006
|
0.94
|
5
|
Effects of IL-15 on rat brown adipose tissue: uncoupling proteins and PPARs.
|
Obesity (Silver Spring)
|
2008
|
0.94
|
6
|
Activation of UCPs gene expression in skeletal muscle can be independent on both circulating fatty acids and food intake. Involvement of ROS in a model of mouse cancer cachexia.
|
FEBS Lett
|
2005
|
0.90
|
7
|
Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
|
Muscle Nerve
|
2008
|
0.88
|
8
|
Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models.
|
Clin Nutr
|
2007
|
0.84
|
9
|
Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists.
|
Cancer Res
|
2007
|
0.82
|
10
|
PPARdelta mediates IL15 metabolic actions in myotubes: effects of hyperthermia.
|
Int J Mol Med
|
2009
|
0.81
|
11
|
Interleukin-15 increases calcineurin expression in 3T3-L1 cells: possible involvement on in vivo adipocyte differentiation.
|
Int J Mol Med
|
2009
|
0.81
|
12
|
Rat liver lipogenesis is modulated by interleukin-15.
|
Int J Mol Med
|
2004
|
0.80
|
13
|
Sepsis induces DNA fragmentation in rat skeletal muscle.
|
Eur Cytokine Netw
|
2004
|
0.80
|
14
|
[Physiology of sarcopenia. Similarities and differences with neoplasic cachexia (muscle impairments in cancer and ageing)].
|
Nutr Hosp
|
2006
|
0.79
|
15
|
Theophylline is able to partially revert cachexia in tumour-bearing rats.
|
Nutr Metab (Lond)
|
2012
|
0.78
|
16
|
Targets in clinical oncology: the metabolic environment of the patient.
|
Front Biosci
|
2007
|
0.77
|
17
|
Patterns of gene expression in muscle and fat in tumor-bearing rats: effects of CRF2R agonist on cachexia.
|
Muscle Nerve
|
2010
|
0.77
|
18
|
Interleukin-15 decreases lipid intestinal absorption.
|
Int J Mol Med
|
2005
|
0.77
|
19
|
Nutraceutical inhibition of muscle proteolysis: a role of diallyl sulphide in the treatment of muscle wasting.
|
Clin Nutr
|
2010
|
0.75
|
20
|
Effects of the PPARgamma agonist GW1929 on muscle wasting in tumour-bearing mice.
|
Oncol Rep
|
2008
|
0.75
|
21
|
Both AP-1 and NF-kappaB seem to be involved in tumour growth in an experimental rat hepatoma.
|
Anticancer Res
|
2009
|
0.75
|
22
|
A differential pattern of gene expression in skeletal muscle of tumor-bearing rats reveals dysregulation of excitation–contraction coupling together with additional muscle alterations.
|
Muscle Nerve
|
2014
|
0.75
|